| Literature DB >> 35731342 |
Hong Shen Wong1, Hadi Wiputra2, Andreas Tulzer3, Gerald Tulzer3, Choon Hwai Yap4.
Abstract
In cases of fetal aortic stenosis and evolving Hypoplastic Left Heart Syndrome (feHLHS), aortic stenosis is associated with specific abnormalities such as retrograde or bidirectional systolic transverse arch flow. Many cases progressed to hypoplastic left heart syndrome (HLHS) malformation at birth, but fetal aortic valvuloplasty can prevent the progression in many cases. Since both disease and intervention involve drastic changes to the biomechanical environment, in-vivo biomechanics likely play a role in inducing and preventing disease progression. However, the fluid mechanics of feHLHS is not well-characterized. Here, we conduct patient-specific echocardiography-based flow simulations of normal and feHLHS left ventricles (LV), to understand the essential fluid dynamics distinction between the two cohorts. We found high variability across feHLHS cases, but also the following unifying features. Firstly, feHLHS diastole mitral inflow was in the form of a narrowed and fast jet that impinged onto the apical region, rather than a wide and gentle inflow in normal LVs. This was likely due to a malformed mitral valve with impaired opening dynamics. This altered inflow caused elevated vorticity dynamics and wall shear stresses (WSS) and reduced oscillatory shear index at the apical zone rather than mid-ventricle. Secondly, feHLHS LV also featured elevated systolic and diastolic energy losses, intraventricular pressure gradients, and vortex formation numbers, suggesting energy inefficiency of flow and additional burden on the LV. Thirdly, feHLHS LV had poor blood turnover, suggesting a hypoxic environment, which could be associated with endocardial fibroelastosis that is often observed in these patients.Entities:
Keywords: Aortic stenosis; Computational fluid dynamics; Fetal heart; Fluid mechanics; Hypoplastic left heart syndrome
Mesh:
Year: 2022 PMID: 35731342 PMCID: PMC9363377 DOI: 10.1007/s10439-022-02990-5
Source DB: PubMed Journal: Ann Biomed Eng ISSN: 0090-6964 Impact factor: 4.219
Characteristics of aortic stenosis with evolving hypoplastic left heart syndrome (feHLHS) fetal subjects before aortic valvuloplasty, postnatal outcomes of the same subjects and postnatal procedures undertaken.
| Case | GA at scan, (week + day) | Brady-cardia | LV throm-bus | Pericardial effusion | Hydrops | Postnatal Circulation | Outcome | Postnatal procedures |
|---|---|---|---|---|---|---|---|---|
| feHLHS - 1 | 22 + 1 | Y | N | N | N | BV | Alive | RK, BV-UV conv., NW |
| feHLHS – 2 | 22 + 4 | N | Y | N | N | UV | Infant death | NW |
| feHLHS – 3 | 29 + 1 | N | N | N | Y | BV | Alive | RK |
| feHLHS – 4 | 29 | N | N | N | Y | BV | Alive | RK |
| feHLHS – 5 | 31 + 6 | N | N | Y | N | BV | Alive | Surg. Valv., Ross |
GA gestational age, LV left ventricle, BV biventricular, UV univentricular, RK Ross-Konno procedure, BV-UV conv. biventricular to univentricular conversion, NW Norwood procedure, Surg. Valv. surgical valvotomy, Y yes, N no
Figure 1Outputs from our Windkessel lumped parameter model showed physiologic A pressure-volume loop and B abdominal aortic pulse pressure across gestational age and C systolic and diastolic pressures of the left ventricle across gestational age. Literature values of clinically measured abdominal aortic pulse pressure by Versmold et al.[34] and LV pressures by Johnson et al.[10] are plotted in B and C as well, demonstrating that our model had a good match with these literature values.
Comparison of cardiac parameters between healthy fetuses and case-specific feHLHS.
| Parameter | Healthy cohort | Disease cohort | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 21–22 week | 28–31 week | Overall mean | feHLHS-1, 22.14 week | feHLHS-2, 22.57 week | feHLHS-3, 29.14 week | feHLHS-4, 29 week | feHLHS-5, 31.86 week | Overall mean | ||
| Peak AV velocity, m/s | 0.66 ± 0.09 [0.57, 0.75] | 0.83 ± 0.12 [0.71, 0.96] | 0.74 ± 0.14 | 1.55 | 1.79 | 2.38 | 1.16 | 2.68 | 1.91 ± 0.62 | 0.009* |
| Diastolic E-wave, m/s | 0.31 ± 0.08 [0.21, 0.40] | 0.40 ± 0.09 [0.31, 0.49] | 0.33 ± 0.14 | 0.77 | – | – | – | 1.31 | – | – |
| Diastolic A-wave, m/s | 0.37 ± 0.06 [0.31, 0.44] | 0.45 ± 0.09 [0.35, 0.55] | 0.41 ± 0.09 | 0.49 | 0.38 | 1.05 | 0.94 | 1.45 | 0.86 ± 0.44 | 0.12 |
| Diastolic E-wave after intervention, m/s | – | – | – | 0.60 | – | 0.80 | 0.40 | 1.10 | 0.73 ± 0.30 | – |
| Diastolic A-wave after intervention, m/s | – | – | – | 0.30 | 0.65 | 1.30 | 0.60 | 1.20 | 0.76 ± 0.37 | – |
| Peak MV Regurg., m/s | – | – | – | 2.70 | 3.04 | 3.15 | 3.12 | 4.66 | 3.33 ± 0.76 | – |
| RV SV, ml | 0.59 ± 0.12 [0.46, 0.71] | 1.67 ± 0.58 [1.07, 2.27] | 1.13 ± 0.57 | 0.73 | 1.09 | 1.56 | 2.30 | 4.29 | 1.99 ± 1.41 | 0.19 |
| LV SV, ml | 0.53 ± 0.16 [0.37, 0.70] | 1.92 ± 0.84 [0.88, 2.96] | 1.16 ± 0.90 | 0.17 | 0.14 | 1.23 | 0.68 | 2.26 | 0.90 ± 0.88 | 0.25 |
| LV SV after intervention, ml | – | – | – | 0.50 | 0.16 | 1.94 | 1.22 | NA | – | – |
| RV EDV, ml | 1.02 ± 0.19 [0.82, 1.22] | 3.92 ± 1.14 [2.72, 5.11] | 2.47 ± 1.29 | 1.30 | 2.91 | 3.16 | 5.29 | 8.28 | 4.19 ± 2.69 | 0.25 |
| LV EDV, ml | 0.90 ± 0.21 [0.68,1.13] | 3.62 ± 1.14 [2.20, 5.03] | 2.14 ± 0.16 | 2.46 | 2.99 | 17.42 | 11.09 | 8.43 | 8.48 ± 6.19 | 0.009* |
| LV EF, % | 59 ± 10 [49, 69] | 53 ± 15 [37, 69] | 56.2 ± 12.0 | 6.80 | 4.63 | 7.06 | 6.25 | 26.8 | 10.3 ± 9.3 | 0.009* |
Data are presented as mean ± SD and [5th percentile, 95th percentile]. For a healthy cohort, data from the current study were combined with those from Hadi et al. [36] NA – There was no clear subject specific image scan data
AV aortic valve, MV mitral valve, RV right ventricle, SV stroke volume, LV left ventricle, EDV end-diastolic volume, EF ejection fraction, Regurg regurgitation
*P < 0.05 comparing all healthy cases to all diseased cases
Figure 2WSS color contour and λ2 iso-velocity surfaces in two representative healthy fetal LVs and five feHLHS LVs. These results are also shown in Supplementary Videos S1–10.
Case-specific mitral valve parameters of healthy LVs and feHLHS LVs.
| Parameter | Healthy cohort | Disease cohort | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| H1 | H2 | H3 | H4 | H5 | Overall mean | feHLHS-1, 22.14 week | feHLHS-2, 22.57 week | feHLHS-3, 29.14 week | feHLHS-4, 29 week | feHLHS–5, 31.86 week | Overall mean | ||
| MV annulus (mm) | 6.60 | 6.50 | 8.00 | 10.5 | 9.60 | 8.2 ± 1.8 | 5.70 | 13.5 | 9.50 | 10.4 | 10.8 | 10.0 ± 2.8 | 0.35 |
MV annulus (z-score) | 0.74 | 0.62 | −0.36 | 0.80 | 0.11 | 0.38 ± 0.50 | 1.28 | − 1.02 | 3.26 | 0.63 | 0.77 | 0.98 ± 1.54 | 0.22 |
| MV jet area (mm2) | 9.00 | 12.5 | 40.7 | 46.4 | 56.1 | 32.9 ± 21.0 | 1.96 | 3.45 | 15.0 | 10.2 | 14.1 | 8.9 ± 6.0 | 0.12 |
| MV jet area/MV annulus (mm) | 1.36 | 3.99 | 5.09 | 4.42 | 5.84 | 4.14 ± 1.70 | 0.19 | 0.61 | 1.11 | 1.07 | 1.30 | 0.86 ± 0.45 | 0.009* |
Data are presented as mean ± SD
MV mitral valve
*P < 0.05 comparing all healthy cases to all diseased cases
Comparison between healthy LVs and feHLHS LVs derived from CFD simulations.
| Parameter | Healthy cohort | Disease cohort | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 21-22 week‡ | 28-31 week‡ | Overall mean | feHLHS-1, 22.14 week | feHLHS-2, 22.57 week | feHLHS-3, 29.14 week | feHLHS-4, 29 week | feHLHS-5, 31.86 week | Overall mean | ||
| Systolic IVPG (Pa) | 194 ± 58 [133, 255] | 292 ± 91 [197, 387] | 242 ± 89 | 1211 | 1607 | 2936 | 697 | 3575 | 2005 ± 1207 | 0.009* |
| Diastolic IVPG (Pa) | 32 ± 11 [21,44] | 51 ± 32 [17, 85] | 41 ± 25 | 91 | 22 | 98 | 105 | 588 | 181 ± 230 | 0.35 |
| Normalised Systolic Ejection Work Done (J/m3) | 123 ± 33 [88,157] | 204 ± 74 [126, 282] | 164 ± 69 | 2256 | 2846 | 2765 | 2534 | 5351 | 3150 ± 1251 | 0.009* |
| Normalised Systolic Energy Loss (J/m3) | 22 ± 6 [15, 29] | 26 ± 7 [19, 32] | 22 ± 8 | 132 | 163 | 212 | 161 | 275 | 188 ± 56 | 0.009* |
| Normalised Diastolic Energy Loss (J/m3) | 16 ± 9 [6, 26] | 22 ± 10 [12, 32] | 17 ± 10 | 114 | 34 | 167 | 97 | 426 | 168 ± 152 | 0.009* |
| Time- & Surface-Ave WSS (Pa) | 0.68 ± 0.19 [0.48, 0.87] | 0.91 ± 0.27 [0.63, 1.19] | 0.77 ± 0.26 | 0.25 | 0.15 | 0.56 | 0.39 | 1.50 | 0.57 ± 0.54 | 0.14 |
| Diastolic Peak Surface-Ave WSS (Pa) | 0.81 ± 0.29 [0.50, 1.12] | 1.11 ± 0.39 [0.71, 1.51] | 0.90 ± 0.38 | 0.51 | 0.18 | 0.91 | 0.56 | 4.04 | 1.21 ± 1.42 | 0.46 |
| Diastolic Time- & Surface-Ave WSS (Pa) | 0.54 ± 0.16 [0.38, 0.71] | 0.81 ± 0.25 [0.55, 1.07] | 0.51 ± 0.36 | 0.27 | 0.14 | 0.46 | 0.38 | 1.78 | 0.61 ± 0.67 | 0.35 |
| Systolic Peak Surface-ave WSS (Pa) | 1.41 ± 0.31 [1.08, 1.74] | 1.69 ± 0.29 [1.39, 2.00] | 1.52 ± 0.36 | 0.31 | 0.23 | 1.03 | 0.50 | 2.77 | 0.97 ± 1.05 | 0.18 |
| Systolic Time- & Surface-Ave WSS (Pa) | 0.85 ± 0.17 [0.67, 1.03] | 1.05 ± 0.20 [0.84, 1.26] | 0.93 ± 0.22 | 0.23 | 0.17 | 0.62 | 0.40 | 1.27 | 0.54 ± 0.44 | 0.15 |
Data are presented as mean ± SD and [5th percentile, 95th percentile]
IVPG intraventricular pressure gradient, Ave averaged, WSS wall shear stress
*P < 0.05 comparing all healthy cases to all diseased cases
‡ Data from healthy patient cases combined with Hadi et al.[36]
Figure 3Surface color contour maps of time-averaged WSS (TAWSS) and oscillatory shear index (OSI) distribution in two representative cases for healthy fetal LVs and five feHLHS LV, organised according to GA group.
Figure 4In-plane contour maps of passive dye mass fraction across the cardiac cycle after 3 cardiac cycles for 2 representative cases of healthy LVs and five feHLHS LVs. Mass fraction of 1 (red) indicates ‘fresh’ blood entering from the mitral valve and mass fraction of 0 (blue) represents ‘old’ blood initially present in the ventricle. *feHLHS-2,3,4 has a monophasic inflow profile. Simulation results for all 5 healthy cases are given in Supplementary Figure S3.
Figure 5Scatterplots evaluating the volume-averaged cumulative dye mass fraction after three cardiac cycles vs. left ventricle ejection fraction (%)
Case-specific vortex formation times obtained from CFD simulations.
| Parameter | Healthy cohort | Disease cohort | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| H1 | H2 | H3 | H4 | H5 | feHLHS-1 | feHLHS-2 | feHLHS-3 | feHLHS-4 | feHLHS–5 | |
| Formation time | 9.3 | 6.84 | 3.5 | 2.3 | 4.7 | 15.1 | 25.9 | 18.4 | 19.4 | 15.1 |